An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome - Kellow, J; Lee, O Y; Chang, F Y (Gut, 2003)
et al.